Summitry LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Buy
1,711
+234
+16% +$239K 0.07% 77
2026
Q1
$1.36M Buy
1,477
+638
+76% +$647K 0.05% 79
2025
Q4
$902K Buy
839
+70
+9% +$66.9K 0.04% 75
2025
Q3
$587K Buy
769
+328
+74% +$244K 0.02% 96
2025
Q2
$344K Buy
441
+31
+8% +$24.1K 0.02% 121
2025
Q1
$339K Buy
410
+16
+4% +$13.3K 0.02% 108
2024
Q4
$304K Sell
394
-152
-28% -$126K 0.01% 106
2024
Q3
$484K Buy
546
+255
+88% +$229K 0.02% 79
2024
Q2
$263K Sell
291
-50
-15% -$40K 0.01% 95
2024
Q1
$265K Buy
+341
New +$243K 0.01% 94
2016
Q4
– Sell
-4,836
Closed -$388K – 83
2016
Q3
$388K Hold
4,836
– – 0.04% 70
2016
Q2
$381K Hold
4,836
– – 0.04% 68
2016
Q1
$348K Sell
4,836
-800
-14% -$60.5K 0.04% 69
2015
Q4
$475K Hold
5,636
– – 0.05% 57
2015
Q3
$472K Hold
5,636
– – 0.05% 51
2015
Q2
$471K Buy
5,636
+800
+17% +$61K 0.05% 48
2015
Q1
$351K Hold
4,836
– – 0.04% 49
2014
Q4
$334K Sell
4,836
-50
-1% -$3.38K 0.04% 53
2014
Q3
$317K Buy
4,886
+50
+1% +$3.17K 0.04% 53
2014
Q2
$301K Hold
4,836
– – 0.04% 54
2014
Q1
$285K Hold
4,836
– – 0.04% 57
2013
Q4
$247K Hold
4,836
– – 0.03% 69
2013
Q3
$243K Hold
4,836
– – 0.04% 61
2013
Q2
$238K Buy
+4,836
New +$263K 0.04% 60

Other funds holding LLY

Summitry LLC's LLY Position: Q2 2026 in Review

Summitry LLC increased its Eli Lilly (LLY) stake by 16% in Q2 2026, buying an estimated $239K and bringing the position to 1,711 shares worth $2.05M. The position accounts for 0.07% of the portfolio, ranked #77.

Summitry LLC first reported a position in LLY in Q2 2013 and has held it in 24 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Summitry LLC held 1,711 shares of Eli Lilly worth $2.05M as of Q2 2026.
  • Summitry LLC bought 234 Eli Lilly shares in Q2 2026, an estimated $239K.
  • Eli Lilly made up 0.07% of Summitry LLC's portfolio in Q2 2026, its #77 holding.
  • Summitry LLC first reported a position in Eli Lilly in Q2 2013 and has held it in 24 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Summitry LLC's 13F filing for Q2 2026, filed 21 Jul 2026.